Assessing Developability of Novel Biotherapeutics Through Mass Spectrometry

Discover how Genedata Expressionist enables scientists at Sanofi to obtain comprehensive, in-depth characterizations of biotherapeutic candidate molecules. Gaining such a deep molecular understanding of candidates during developability studies leads to much lower attrition rates in later stages, less-problematic processes, and ultimately, a faster time in clinic with best-in-class biotherapeutics.